-
公开(公告)号:JP2000109475A
公开(公告)日:2000-04-18
申请号:JP31294099
申请日:1999-11-02
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound useful as an intermediate for producing a water-soluble camptothecin derivative used for treating tumors. SOLUTION: A compound of formula I [(n) is 1 or 2; R1, R2 are each H, a 1-6C alkyl or the like, or R1 is H, a 1-6C alkyl or the like and R2 is a group of the formula; COR3, or R1 and R2 are bonded to each other together with a nitrogen atom bonded thereto to form a saturated three to seven-membered heterogeneous group; R3 is H, a 1-6C alkyl or the like; Y is O, S or the like], for example, 2'-amino-4',5'-methylenedioxy-2-trifluoroacetamidoacetophenone. The compound of formula I is obtained by reacting a compound of formula III (X is a halogen) (for example, 2'-amino-4',5'-methylenedioxy-2- chloroacetophenone) with a compound of the formula: HNR1R2 (for example, trifluoroacetamine) in the presence of a base in an aprotic polar solvent such as acetonitrile.
-
公开(公告)号:SK323792A3
公开(公告)日:1998-09-09
申请号:SK323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/47 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , A61K31/33
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CZ284023B6
公开(公告)日:1998-07-15
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:PL173684B1
公开(公告)日:1998-04-30
申请号:PL29870593
申请日:1993-04-26
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: C07D491/12 , C07D491/22
-
公开(公告)号:IS4152A
公开(公告)日:1994-10-30
申请号:IS4152
申请日:1994-04-25
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY MARK , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22
-
公开(公告)号:NO924158L
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/47 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CA2081580A1
公开(公告)日:1993-04-30
申请号:CA2081580
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , C07D405/06 , C07D413/06 , C07D417/06 , A61K31/495 , A61K31/535 , A61K31/54
Abstract: GLX-76/AC155 WATER SOLUBLE CAMPTOTHECIN DERIVATIVES The invention relates to water soluble, camptothecin derivatives of formula (1), (I) wherein: n represents the integer 1 or 2; and i) R1 and R2 represent independently, hydrogen, lower alkyl, (C3 7)cycloalkyl;(C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R1 represents hydrogen, lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R2 represents -COR3 wherein R3 represents hydrogen, lower alkyl, perhalo-lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R1 and R2 taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH2, NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:MY141374A
公开(公告)日:2010-04-16
申请号:MYPI9401039
申请日:1994-04-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY MARK , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: C07D491/22 , A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18
Abstract: THE PRESENT INVENTION RELATES TO WATER SOLUBLE, CAMPTOTHECIN DERIVATIVES OF FORMULA (I) WHEREIN N REPRESENTS THE INTEGER 1 OR 2; AND I) R1 REPRESENTS HYDROGEN, LOWER ALKYL, (C3-7)CYCLOALKYL, (C3-7)CYCLOALKYL LOWER ALKYL, LOWER ALKENYL, HYDROXY LOWER ALKYL, AMINO LOWER ALKYL, LOWER ALKYLAMINO LOWER ALKYL, AMINO LOWER ALKYL, LOWER ALKOXY LOWER ALKYL OR (CH2)TAR WHEREIN: T IS 0 TO 5 AND AR REPRESENTS PHENYL, FURYL, PYRIDYL, N-METHYLPYRROLYL, IMIDAZOLYL; OR PHENYL, FURYL, PYRIDYL, N-METHYLPYRROLYL, IMIDAZOLYL, WITH ONE OR MORE SUBSTITUENTS INDEPENDENTLY SELECTED FROM HYDROXY, METHOXY, HALOGEN AND AMINO; AND R2 REPRESENTS DIPHENYLMETHYL OR (CH2)TAR; OR II) R1 AND R2 TAKEN TOGETHER WITH THE LINKING NITROGEN REPRESENT N-TETRAHYDROQUINOLYL OR N-TETRAHYDROISOQUINOLYL; AND PHARMACEUTICALLY ACCEPTABLE SALTS AND SOLVATES THEREOF; THEIR USE AS TOPOISOMERASE INHIBITORS; THEIR PREPARATION; AND THEIR USE IN THE TREATMENT OF CANCER.
-
公开(公告)号:ZA942808B
公开(公告)日:1995-01-18
申请号:ZA942808
申请日:1994-04-22
Applicant: GLAXO INC
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:OA09767A
公开(公告)日:1993-11-30
申请号:OA60295
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/47 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
-
-
-
-
-
-
-
-